Business Segments · Cost of products sold
MedSurg — Cost of products sold
Boston Scientific MedSurg — Cost of products sold decreased by 9.6% to $478M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.9%, from $435M to $478M. Over 3 years (FY 2022 to FY 2025), MedSurg — Cost of products sold shows an upward trend with a 11.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2022
Last reportedQ1 2026May 1, 2026
How to read this metric
Rising costs relative to sales may indicate manufacturing inefficiencies or inflationary pressure on raw materials.
Detailed definition
The direct costs associated with manufacturing and delivering the products sold by the MedSurg segment. This includes ra...
Peer comparison
Standard cost of goods sold (COGS) metric for manufacturing-heavy business segments.
Metric ID:
bsx_segment_medsurg_cost_of_products_soldHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $350.25M | $350.25M | $350.25M | $350.25M | $367.75M | $367.75M | $367.75M | $367.75M | $381M | $401M | $412M | $457M | $435M | $470M | $483M | $529M | $478M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +5.0% | +0.0% | +0.0% | +0.0% | +3.6% | +5.2% | +2.7% | +10.9% | -4.8% | +8.0% | +2.8% | +9.5% | -9.6% |
| YoY Change | — | — | — | — | +5.0% | +5.0% | +5.0% | +5.0% | +3.6% | +9.0% | +12.0% | +24.3% | +14.2% | +17.2% | +17.2% | +15.8% | +9.9% |
Range$350.25M – $529M
CAGR+8.1%
Avg YoY Growth+11.0%
Median YoY Growth+9.9%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's medsurg — cost of products sold?
- Boston Scientific (BSX) reported medsurg — cost of products sold of $478M in Q1 2026.
- How has Boston Scientific's medsurg — cost of products sold changed year-over-year?
- Boston Scientific's medsurg — cost of products sold increased by 9.9% year-over-year, from $435M to $478M.
- What is the long-term trend for Boston Scientific's medsurg — cost of products sold?
- Over 3 years (2022 to 2025), Boston Scientific's medsurg — cost of products sold has grown at a 11.0% compound annual growth rate (CAGR), from $1.4B to $1.92B.
- What does medsurg — cost of products sold mean?
- The total direct cost to produce and deliver the goods sold by the MedSurg segment.